Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 180.00
+1.90 (1.07%)
Jun 30, 2026, 4:08 PM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 14.17 billion as of June 30, 2026.
Market Cap
14.17B
Enterprise Value
12.81B
Revenue
648.05M
Ranking
n/a
PE Ratio
63.51
Stock Price
180.00
Market Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 14.17B, an increase of 72.74%. That is a compound annual growth rate of 120.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 14.17B | 32.35% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Medical System Holdings | 25.54B |
| Simcere Pharmaceutical Group | 25.30B |
| Sunshine Lake Pharma | 23.04B |
| The United Laboratories International Holdings | 16.63B |
| Grand Pharmaceutical Group | 16.46B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Consun Pharmaceutical Group | 10.82B |
| CanSino Biologics | 9.68B |